Patrick Soon-Shiong critiques chemo-radiation in failed RAPIDO trial

Patrick Soon-Shiong critiques chemo-radiation in failed RAPIDO trial
@DrPatSoonShiong: Soon-Shiong critiques chemo-radiation

The recent commentary by Patrick Soon-Shiong sheds light on critical issues in cancer treatment following the failed RAPIDO trial.

Patrick Soon-Shiong, a renowned physician and entrepreneur, emphasizes the detrimental effects of chemo-radiation on the immune system. He points out that this treatment approach, pursued for decades, reduces the Absolute Lymphocyte Count (ALC), a measure of natural killer (NK) and T cells. These are vital components of the immune system crucial for combating cancerous cells.

The RAPIDO trial's failure highlights the need for a reassessment of current treatment methodologies. According to Soon-Shiong, the decreasing ALC count, often overlooked, is critical for understanding why chemo-radiation might not be as effective as believed. His insights serve as a call for the medical community to reevaluate treatment strategies that prioritize boosting immune health over continued reliance on traditional chemo-radiation protocols.

Soon-Shiong’s broader efforts to reshape oncological care build on his commitment to innovative medical technologies, as seen with his introduction of Airstrip for advanced healthcare monitoring. His perspective on immunotherapy also resonates with the encouraging outcomes reported in the HPV cancer Bioshield trials, further underscoring the potential of immune-based strategies in improving patient prognosis.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.